You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
濟川藥業(600566.SH):“年產7.2億袋小兒豉翹清熱顆粒項目”正在進行淨化工程安裝
格隆匯 01-02 17:00

格隆匯1月2日丨濟川藥業(600566.SH)公佈,連日來,隨着新冠肺炎疫情防控新十條措施、新型冠狀病毒感染實施“乙類乙管”相繼出台疊加冬季流感季的到來,國內對清熱解毒類以及兒童感冒類藥品的需求大幅提升。針對清熱解毒類以及兒童感冒類醫療物資供應緊張的情況,公司積極響應政府的號召,努力供應清熱解毒類以及兒童感冒類產品用藥,嚴格落實生產規範及安全生產防範措施,加緊作業,優化排產、執行車間機器不停轉、員工輪崗、錯峯休假的生產計劃,確保最大限度釋放產能,保障蒲地藍消炎口服液和小兒豉翹清熱顆粒的生產和供應。

經中國證券監督管理委員會證監許可〔2020〕1442號文核准,公司非公開發行人民幣普通股7332.9853萬股,發行價格為每股19.16元,募集資金總額人民幣14.05億元,扣除相關的發行費用人民幣2122.8萬元(不含税)後,實際募集資金淨額為人民幣138377.2萬元,其中公司擬使用44877.2萬元募集資金用於“年產7.2億袋小兒豉翹清熱顆粒”募投項目(“募投項目”、“該募投項目”)。截至目前,公司該募投項目正在進行淨化工程安裝,預計2023年下半年開始調試及試生產工作。

針對兒童感冒類醫療物資供應緊張的情況,公司積極響應政府的號召,嚴格落實生產規範及安全生產防範措施,加緊作業,優化排產、執行車間機器不停轉、員工輪崗、錯峯休假的生產計劃,確保最大限度釋放產能,目前小兒豉翹清熱顆粒保持滿負荷生產狀態,可保障每天超過100萬袋小兒豉翹清熱顆粒的生產和供應。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account